Why AI scribes are a malpractice risk, according to experts
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Lured by promises of time savings and more face-to-face interactions with patients,…
-
-
Thyme Care Secures Over $125M, Launches Thyme Companies to Scale Oncology Innovation
What You Should Know Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M, led by Morgan Health. Strategic and institutional syndication includes major…
-
Evaluating foundation models on official German medical licensing examinations: Implications for high-stakes assessment and AI-assisted medical education
Overall performance on the full benchmark in vision-capable models To assess end-to-end multimodal performance, we first evaluated vision-capable models on the full benchmark, defined as all retained items for the…
-
Medtronic recalls pH monitoring capsule linked to 184 serious injuries
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic has recalled a pH monitoring capsule over a risk…
-
Novartis drug cuts inflammation. A heart outcomes study is to come
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A newly acquired Novartis drug successfully lowered signs…
-
Physicians want compensation boost from AI productivity gains: survey
Dive Brief: More than 40% of doctors think they should capture most of the cost savings if artificial intelligence helps them work faster, according to a new survey from health…
-
Metriport Raises $26M to Scale Open-Source Point-of-Care Clinical Intelligence
What You Should Know Open-source healthcare data infrastructure company Metriport secured $26M in new funding led by TJ Parker, General Partner at Matrix, with participation from ARTIS Ventures and Y…
-
Abbott receives FDA nod for dual-analyte sensor
Dive Brief: Abbott has received Food and Drug Administration authorization for a dual-analyte sensor that can measure both glucose and ketones. Abbott announced the de novo authorization on Tuesday after…
-
With Medicaid cuts looming, rural hospitals already making changes
BANGOR, Maine — Last year, Republicans set American health care on a new path: They slashed $1 trillion from expected Medicaid funding over the next decade and allowed tens of…
-
Doctors say they feel pressured to prioritize corporate interests over patients: report
Dive Brief: Nearly half of physicians employed by corporations feel pressured to prioritize patient volume over care quality, according to a new survey of 1,000 doctors from a physician advocacy…
